MEDARTIS HOLDING AG MED.SW · Stock Open MEDARTIS HOLDING AG in new tab
MEDARTIS HOLDING AG Analysis (MED.SW)
Is MEDARTIS HOLDING AG a good investment? MEDARTIS HOLDING AG (MED.SW) is currently trading at 86.80 CHF. Market analysts have a consensus price target of 98.33 CHF. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 131.64. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: MEDARTIS HOLDING AG is expected to release its next earnings report on Aug. 18, 2026. The market consensus estimate for Forward EPS is 2.24.
Investor FAQ
Does MEDARTIS HOLDING AG pay a dividend?
No, it does not currently pay a dividend.
What asset class is MEDARTIS HOLDING AG?
MEDARTIS HOLDING AG is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 18, 2026. The company currently has a trailing EPS of 0.67.
Company Profile
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.
Community Discussion